SUDARSHAN PHARMA INDUSTRIES LI (SUDARSHAN)

BSE: ₹34.47
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 265.84 231.80 231.74 227.79 277.26 145.26 168.87 168.01 388.93
YOY Revenue Growth % - - - - 4.29% -37.33% -27.13% -26.25% 40.28%
Other Income 0.71 1.94 0.66 1.25 1.27 1.21 1.86 1.52 5.64
Total Income 266.55 233.74 232.40 229.04 278.53 146.47 170.73 169.52 394.57
Total Expenses + 261.76 227.22 223.70 219.84 263.28 141.06 166.50 164.33 373.67
Cost of Materials Consumed 0.32 3.14 3.17 3.66 5.27 5.42 0.31 13.21 33.33
Employee Benefit Expense 1.90 1.61 2.03 2.28 2.62 1.58 1.78 1.97 4.08
Other Expenses 6.53 6.62 7.99 9.35 11.13 3.42 5.57 7.36 15.94
Operating Profit 4.08 4.58 8.04 7.95 13.98 4.20 2.36 3.68 15.26
OPM % 1.5% 2% 3.5% 3.5% 5% 2.9% 1.4% 2.2% 3.9%
Profit Before Tax + 4.79 6.52 8.71 8.02 13.60 5.41 4.23 5.20 20.90
Tax Expense 4.79 6.52 8.71 8.02 13.60 1.45 0.36 1.05 5.36
Tax % 100% 100% 100% 100% 100% 26.8% 8.4% 20.2% 25.7%
Profit After Tax 0.00 0.00 0.00 0.00 0.00 3.96 3.87 4.15 15.54
EPS (Basic) 2.75 2.02 2.74 2.46 0.41 0.16 0.16 0.18 0.65

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
Revenue from Operations 703.06 505.05 463.54 461.33
YOY Revenue Growth % 39.21% 8.95% 0.48% -
Other Income 8.71 2.52 2.61 1.12
Total Income 711.77 507.57 466.15 462.45
Total Expenses + 681.23 483.12 450.92 452.95
Cost of Materials Consumed 39.06 8.93 6.31 0.32
Employee Benefit Expense 7.44 4.89 3.64 2.98
Other Expenses 24.93 20.48 14.61 12.72
Operating Profit 21.83 21.93 12.62 8.38
OPM % 3.1% 4.3% 2.7% 1.8%
Profit Before Exceptional 30.54 0.00 0.00 0.00
Exceptional Items 0.00 0.00 0.00 0.00
Profit Before Tax + 30.54 21.63 15.23 9.50
Tax Expense 7.17 21.63 15.23 9.50
Tax % 23.5% 100% 100% 100%
Profit After Tax 23.37 0.00 0.00 0.00
EPS (Basic) 0.97 0.66 4.76 5.48

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
ASSETS
Non-Current Assets + 151.48 67.56 41.55 33.86
Property, Plant & Equipment 77.41 20.05 0.00 0.00
Capital Work in Progress 3.44 0.00 0.00 0.00
Non-Current Investments 0.00 28.84 12.34 12.34
Goodwill 5.22 0.00 0.00 0.00
Other Intangible Assets 9.97 0.00 0.00 0.00
Current Assets + 490.26 334.85 241.57 198.62
Inventories 218.74 140.48 85.74 74.57
Trade Receivables 233.34 0.00 0.00 0.00
Cash and Cash Equivalents 1.13 0.06 0.14 11.72
Current Investments 0.00 1.50 1.50 0.00
LIABILITIES & EQUITY
Total Equity 156.32 0.00 0.00 0.00
Equity Share Capital 24.07 0.00 0.00 0.00
Other Equity 131.03 0.00 0.00 0.00
Non-Current Liabilities 29.31 11.26 10.59 13.03
Current Liabilities 456.12 259.74 160.82 118.48
Total Liabilities 485.43 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
Cash from Operating Activities -2.30 -26.09 -73.26 -24.46
Cash from Investing Activities -77.70 -20.41 5.24 -26.33
Cash from Financing Activities 80.58 46.87 56.44 62.27
Net Increase/Decrease in Cash 0.58 0.37 -11.57 11.48